Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin.
Solé A, Part-Lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-Martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Solé A, et al. Among authors: anguera g. Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):493-498. doi: 10.1016/j.arbres.2019.10.013. Epub 2019 Nov 23. Arch Bronconeumol (Engl Ed). 2020. PMID: 31771919 English, Spanish.
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.
García-Ortega A, Oscullo G, Calvillo P, López-Reyes R, Méndez R, Gómez-Olivas JD, Bekki A, Fonfría C, Trilles-Olaso L, Zaldívar E, Ferrando A, Anguera G, Briones-Gómez A, Reig-Mezquida JP, Feced L, González-Jiménez P, Reyes S, Muñoz-Núñez CF, Carreres A, Gil R, Morata C, Toledo-Pons N, Martí-Bonmati L, Menéndez R, Martínez-García MÁ. García-Ortega A, et al. Among authors: anguera g. J Infect. 2021 Feb;82(2):261-269. doi: 10.1016/j.jinf.2021.01.003. Epub 2021 Jan 10. J Infect. 2021. PMID: 33440207 Free PMC article.
Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021.
Tapia JC, Bosma F, Gavira J, Sanchez S, Molina MA, Sanz-Beltran J, Martin-Lorente C, Anguera G, Maroto P. Tapia JC, et al. Among authors: anguera g. Clin Genitourin Cancer. 2024 Feb 1;22(3):102047. doi: 10.1016/j.clgc.2024.01.019. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38430859
Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis.
Tapia JC, Gavira J, Anguera G, Sanchez S, Romano A, Bosma F, Molina A, Sanz-Beltran J, Martin-Lorente C, Algaba F, Maroto P. Tapia JC, et al. Among authors: anguera g. Clin Transl Oncol. 2024 Feb 29. doi: 10.1007/s12094-024-03393-9. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38421563
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO; THOR Cohort 1 Investigators. Loriot Y, et al. N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870920 Clinical Trial.
62 results